CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde is out of specification in the affected lots.

The level of the degradation product Benzaldehyde is out of specification in the affected lots.

Product quality

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE

RA-76972